- Home
- ELWS vs COSM Comparison
ELWS vs COSM Comparison
Compare ELWS & COSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ELWS | COSM |
|---|---|---|
| Founded | 2018 | 2009 |
| Country | Japan | United States |
| Employees | N/A | N/A |
| Industry | | Other Pharmaceuticals |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.4M | 15.4M |
| IPO Year | 2023 | 2013 |
Fundamental Metrics
Financial Performance| Metric | ELWS | COSM |
|---|---|---|
| Price | $5.46 | $0.41 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 24.9K | ★ 616.4K |
| Earning Date | 12-31-2025 | 11-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $3,083,071.00 | ★ $59,792,819.00 |
| Revenue This Year | N/A | $28.14 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 145.52 | 6.69 |
| 52 Week Low | $1.64 | $0.28 |
| 52 Week High | $10.50 | $1.32 |
Technical Indicators
Market Signals| Indicator | ELWS | COSM |
|---|---|---|
| Relative Strength Index (RSI) | 55.46 | 20.91 |
| Support Level | $5.38 | $0.44 |
| Resistance Level | $6.11 | $0.46 |
| Average True Range (ATR) | 0.30 | 0.05 |
| MACD | -0.05 | -0.00 |
| Stochastic Oscillator | 48.38 | 1.60 |
Price Performance
Historical ComparisonAbout ELWS Earlyworks Co. Ltd.
Earlyworks Co Ltd is a blockchain-based technology company. It builds products, delivers services, and develops solutions based on a proprietary grid ledger system to leverage blockchain technology in various business settings, including advertisement tracking, online visitor management, and sales of non-fungible tokens. The company's customers represent a diverse range of industries, such as information technology, shipping, real estate, entertainment, cosmetics, and chemical products.
About COSM Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.